Al's Comment:

Very impressive results for GammaTile. For recurrent Glioblastoma patients with methylated MGMT, overall survival reached 37 months. For Unmethylated, survival was 20 months, which is still very impressive!

GammaTile are implantable tiles that release radiation to the tumor bed. They are FDA approved.  Since they are relatively new, they are not yet available at all hospitals, so if you are going to have a brain tumor surgery, ask your doctor if GammaTile is appropriate for your case. If he says no, check the https://gammatile.com/findatreatmentcenter/ website to see if your center has experience with GammaTile.  If not, get a second opinion from one of the centers listed.


Posted on: 05/19/2022

GT Medical Technologies Announces the Presentation of Clinical Data on GammaTile® Therapy in the Treatment of Recurrent Glioblastomas at the 2022 American Association of Neurological Surgeons Scientific Meeting

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click
HERE to read it!